Literature DB >> 3545929

Glucose tolerance tests and "in vivo" response to intravenous insulin in the unanaesthesized late pregnant rat and their consequences to the fetus.

A Martin, A Zorzano, I Caruncho, E Herrera.   

Abstract

In the late pregnant rat, blood glucose levels were lower and plasma RIA-insulin levels were slightly higher than in virgin animals. Oral and intravenous glucose tolerance tests produced parallel changes in blood glucose in both groups whereas plasma RIA-insulin increased more in the pregnant animals. Blood glucose levels after either low (0.1-1 IU/kg) or high (10 IU/Kg) doses of intravenous insulin decreased more slowly and less in pregnant than in virgin rats. Fetal blood glucose levels were not affected by maternal insulin treatment. Results show that in the unanaesthesized late pregnant rat both insulin sensitivity and responsiveness decreased and it is proposed that this insulin resistance may represent a mechanism to delay disposal of ingested nutrients by maternal tissues, ensuring their availability to the fetus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3545929

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  3 in total

1.  Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.

Authors:  Ana Soria; Maria del Carmen González; Hubert Vidal; Emilio Herrera; Carlos Bocos
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  Physiological, mitochondrial, and oxidative stress differences in the presence or absence of lactation in rats.

Authors:  Hayden W Hyatt; Yufeng Zhang; Wendy R Hood; Andreas N Kavazis
Journal:  Reprod Biol Endocrinol       Date:  2018-01-09       Impact factor: 5.211

3.  Lactation has persistent effects on a mother's metabolism and mitochondrial function.

Authors:  Hayden W Hyatt; Yufeng Zhang; Wendy R Hood; Andreas N Kavazis
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.